Sale!

GLB1 Gene GM1-Gangliosidosis Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GLB1 Gene GM1-Gangliosidosis Type 1 Genetic Test is a specialized diagnostic tool used to detect mutations in the GLB1 gene, which are responsible for GM1-gangliosidosis type 1, a rare inherited lysosomal storage disorder. This condition is characterized by a wide spectrum of symptoms, ranging from severe neurological impairment to skeletal abnormalities, depending on the severity and type of mutation present. Early detection through this genetic test can be crucial for management and treatment options, potentially improving the quality of life for affected individuals.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test provides a comprehensive analysis of the GLB1 gene to identify specific mutations associated with the disease. The cost of the test is set at 4400 AED, reflecting the intricate processes involved in ensuring accurate and reliable results. By choosing DNA Labs UAE for this test, individuals can expect state-of-the-art technology and expertise, contributing to the early diagnosis and understanding of GM1-gangliosidosis type 1.

Description

GLB1 Gene GM1-gangliosidosis type 1 Genetic Test

Test Name: GLB1 Gene GM1-gangliosidosis type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GLB1 Gene GM1-gangliosidosis type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GM1-gangliosidosis type 1.

Test Details:

The GLB1 gene is responsible for providing instructions to produce an enzyme called beta-galactosidase. This enzyme is involved in breaking down a fatty substance called GM1-ganglioside, which is found in the nervous system. Mutations in the GLB1 gene can lead to a deficiency in beta-galactosidase activity, resulting in the accumulation of GM1-ganglioside in various tissues.

GM1-gangliosidosis type 1 is a rare genetic disorder characterized by the deficiency of beta-galactosidase activity. This leads to the accumulation of GM1-ganglioside primarily in the brain and spinal cord, causing progressive damage to the nervous system.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the case of GM1-gangliosidosis type 1, NGS genetic testing can be used to identify mutations in the GLB1 gene. This can help in confirming a diagnosis, determining the specific genetic mutation responsible for the disease, and providing information about the inheritance pattern.

NGS genetic testing can be performed on a blood or saliva sample, and the results are usually interpreted by a genetic counselor or a medical geneticist. The information obtained from the test can be used to guide medical management, provide genetic counseling to affected individuals and their families, and potentially inform the development of targeted therapies in the future.

Test Name	GLB1 Gene GM1-gangliosidosis type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for GLB1 Gene GM1-gangliosidosis type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GM1-gangliosidosis type 1
Test Details	The GLB1 gene is responsible for providing instructions to produce an enzyme called beta-galactosidase. This enzyme is involved in breaking down a fatty substance called GM1-ganglioside, which is found in the nervous system. Mutations in the GLB1 gene can lead to a deficiency in beta-galactosidase activity, resulting in the accumulation of GM1-ganglioside in various tissues. GM1-gangliosidosis type 1 is a rare genetic disorder characterized by the deficiency of beta-galactosidase activity. This leads to the accumulation of GM1-ganglioside primarily in the brain and spinal cord, causing progressive damage to the nervous system. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the case of GM1-gangliosidosis type 1, NGS genetic testing can be used to identify mutations in the GLB1 gene. This can help in confirming a diagnosis, determining the specific genetic mutation responsible for the disease, and providing information about the inheritance pattern. NGS genetic testing can be performed on a blood or saliva sample, and the results are usually interpreted by a genetic counselor or a medical geneticist. The information obtained from the test can be used to guide medical management, provide genetic counseling to affected individuals and their families, and potentially inform the development of targeted therapies in the future.